FDA clears Signostics' pocket-sized ultrasound

Signostics has secured FDA clearance for Signos, a palm-sized personal ultrasound device.

The Palo Alto, Calif.-based Signostics has developed an ultrasound device for health professionals to use in clinical practice. With a weight of approximately half a pound, its portability and "low price" is designed for medical markets, including emergency medicine, primary care, remote healthcare, critical care, pediatrics, musculoskeletal, palliative care and sports medicine, the company said.

The company said its Signos delivers images anywhere, at any time for general medical applications, including: abdominal assessments, such as bladder, abdominal aortic aneurysm screening and trauma assessment; musculoskeletal; and basic obstetrics, such as pregnancy viability and fetal positioning.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.